Performance testing of two new one-step real time PCR assays for detection of human influenza and avian influenza viruses isolated in humans and Respiratory 
Syncytial Virus by Valle, L et al.
127
Introduction
The influenza A and B viruses as well as Respiratory
Syncytial Virus (RSV) are prominent among viral cau-
ses of respiratory illness. A rapid and sensitive assay
for the detection of Influenza virus and RSV, in clinical
samples from subjects with influenza-like illness (ILI),
bronchiolitis or pneumonia is a fundamental tool for
various reasons, concerning the epidemiological and
virological surveillance as well as the management of
the patient. First of all, intensive influenza surveillance
efforts are continuously conducted to monitor for the
emergence of pandemic strains and to monitor antige-
nic drift so that an effective vaccine can be produced
annually. This epidemiological and virological surveil-
lance, coordinated by WHO, requires a sensitive proce-
dure not only to detect the virus, but also to effect iso-
lation by cell culture. Secondly, the contribution of
RSV to respiratory illness in adults has not been fully
elucidated and the availability of a rapid and inexpen-
sive assay may contribute to gathering information
concerning the epidemiology of this virus. Finally, a ra-
pid diagnostic test would allow a specific diagnosis to
be made at an early stage of the disease and thus help
the clinician in making therapeutic decisions and to
prevent nosocomial infections. The availability of im-
proved drug treatment with neuraminadase inhibitors,
for influenza viruses, has emphasized the importance
of an efficient laboratory test. Early diagnosis of RSV
could be useful, although controversy exists regarding
ribavirin and immunoglobulin therapy [1]. Current
methods used in the diagnosis of influenza and RSV in-
fection include cell culture isolation, direct antigen de-
tection and serology. The major limitations of these te-
chniques are prolonged time to completion, subjective
evaluation, low sensitivity and low specificity. The in-
troduction of nucleic acid amplification techniques has
made sensitive diagnosis of influenza and RSV feasible
and real time approach has made it rapid [2-5].
Aim of the present report is to describe the evaluation
of the performance in terms of dynamic range, linea-
rity, specificity, analytical and clinical sensitivity, and
the suitability of a new real time PCR for typing in-
fluenza viruses and detection of RSV. The new assay
was designed to detect (i) influenza A, subtype H1N1
and H3N2, including the new A/H3N2/Hong
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Introduction and Methods. Two real time one-step RT-PCR
assays were developed for simultaneous detection and typing
of influenza A and B viruses and detection of Respiratory Syn-
cytial Virus (RSV). As regard influenza, primers were designed
to amplify specific sequences of gene M of A/H1N1, A/H3N2,
A/H5N1, A/H7N7 and A/H9N2 viruses and of gene NP of type
B viruses belonging both Yamagata and Victoria lineage. Speci-
ficity, analytical and clinical sensitivity, dynamic range, lin-
earity of the new assays were evaluated.
Results. Dynamic ranges for Influenza A and B, and RSV,
were at least five logs and linearity was conserved. In order
to evaluate the specificity, 80 nasopharyngeal swabs result-
ing Influenza and RSV negative by multiplex nested PCR and
cell culture, were tested and 79 resulted negative. The detec-
tion limits for influenza A and B, calculated by 95% probit,
was 0,008 and 0,09 PFU, respectively, resulting more sensi-
ble than nested PCR. A total of 75 specimens (10 A/H1N1, 3
A/H1N2, 8 A/H3N2 Johannesburg/94-like, 10 A/H3N2
Panama/2007/99-like, 10 A/H3N2 Fuijian/411/02-like, 2
A/H5N1, 2 A/H7N7 and 2 A/H9N2, 15 B/Yamagata-like and
13 B/Victoria-like) collected between 1994 and 2004 or
received by WHO Influenza Centre, London, were chosen as
representative of the circulating strains and tested. All sam-
ples resulted positive although one B/Victoria sample was not
clear typed. Thirty swabs nested RT-PCR positive for RSV col-
lected during the four seasons, were also analysed by real-
time PCR, resulting positive. To evaluate the performance of
the new assay on fresh material, 250 specimens, collected
during the 2004/05 seasons, were tested by nested-PCR, cell
culture and real-time PCR.
Discussion and Conclusion. The new assays provide accurate
and sensitive diagnosis of influenza and RSV infection and they
represent a sensitive tool for virological surveillance and man-
agement of patient with ILI.
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Kong/1143/02-like variant, appeared during the 2002-
03 season, (ii) avian influenza A virus recently infec-
ting humans (H5N1, H9N2, H7N7) and (iii) the two li-
neages of influenza B (Victoria/2/87 and Yamaga-
ta/16/88 lineages), that co-circulate since 2001/02 sea-
son [6-8].
Methods
REAL TIME PCR
Primer design
Primers were designed from conserved regions of ge-
nes codifying the Matrix Protein, the Nucleoprotein
and Fusion protein of Influenza virus type A, B and
RSV, respectively. Sequences of influenza A, influen-
za B and RSV isolates were selected with FASTA
software [9] and multi-aligned with CLUSTALW
software [10]. Multi-alignments were used to select hi-
ghly conserved regions using MEGA package, version
1.01 of the Pennsylvania State University (PA, USA).
Primers were designed manually to obtain homoge-
neous melting temperatures calculated with AnnHyb
software [11 12]. Primers and probes sequences for in-
fluenza A, influenza B and RSV were as follow:
FLUAV_FOR 5’- ACA AgA CCA ATC CTg TCA CCT
CT-3’; FLUAV_REV 5’- ggC ATT TTg gAC AAA
gCg TCT AC-3’; FLUAV_TM 5’-FAM- CAg TCC
TCg CTC ACT ggg CAC ggT(p)-BHQ1-3’;
FLUBV_FOR 5’- CCA gTg ggA CAA CCA Ga-3’;
FLUBV_REV 5’- TgC TCT TTC Cgg ggA Tg-3’;
FLUB_TM 5’-JOE- ATC ATC AgA CCA gCA ACC
CTT gCC (p)- BHQ1-3’; RSVA_FOR 5’- CCA TAT
ATT gAA CAA CCC AAA AgC ATC 3’; RSVA_REV
5’- TgT ACC TCT gTA CTC TCC CAT TAT 3’;
RSVA_TM 5’-FAM- Agg CCA gCA gCA TTg CCT
AAT ACT ACA(p)- BHQ1-3’; RSVB_FOR 5’- ACC
ATA TAT TgA ACA ATC CAA AAg CAT C 3’;
RSVB_REV 5’- TgT ACC TCT ATA CTC TCC CAT
TAT gC 3’; RSVB_TM 5’-FAM – ACC TgC TgC ATT
gCC TAg gAC CAC(p)- BHQ1-3’.
Procedure
Viral RNA was extracted with QIA techniques, accor-
ding to the manufacturer’s instructions (RNeasy Mi-
nikit, Qiagen, Valencia, CA, USA). Real Time PCR
was performed using Fast Set Inf A/Inf B and Fast Set
RSV A/B (Arrow Diagnostics, Genoa). The reaction
mixture consisted of 2x reaction mix (Invitrogen, Carl-
sbad, CA, USA), PCR additive I, Flu mix (primer 250
nM, TaqMan probe 75 nM) or RSV mix (primer 300
nM, TaqMan probe 100 nM) respectively, SuperScript
III RT/Platinum Taq mix, RNase OUT and 10 µl of
template with a total volume of 50 µl. The PCR thermal
profile consisted of initial RT step of 15 min at 50 °C
followed by 2 min at 95 °C and 35 cycles of 15 sec at
95 °C and 60 sec at 62 °C or 60 sec at 60 °C for In-
fluenza A, B and RSV respectively.
With regard to influenza type A and B multiple fluore-
scent signals were obtained with detectors correspon-
ding to FAM and JOE respectively. RSV signal was ac-
quired on FAM. Real Time Measurements were taken
and a threshold cycle (Ct) value for each sample was
calculated determining the point at which the fluore-
scence exceeded a threshold limit of 0,01.
Amplification, detection and data analysis were perfor-
med with Rotor-Gene 3000 (Corbett Research, Austra-
lia).
MULTIPLEX NESTED PCR
Procedure
Viral RNA was extracted with QIA techniques, accor-
ding to the manufacturer’s instructions (RNeasy Minikit,
Qiagen, Valencia, CA, USA). RT was performed using
random primers (RT-kit plus, Amplimedical, Buttigliera
Alta, Torino, Italy). The first amplification was carried
out by adding previously synthesized cDNA and DNA
polymerase to the pre-aliquoted mix, that contained the
3 pairs of outer primers, KCl, Tris-HCl, Triton X-100;
MgCl2, dNTPs (Influenza/RSV Multiplex, Amplimedi-
cal, Buttigliera Alta, Torino, Italy). The second amplifi-
cation was performed using the pre-aliquoted mix, con-
taining the 3 pairs of inner primers. Biochemical optimi-
sation of the amplification condition was performed and
a final condition of 2 mM MgCl2, 50 mM KCl and pH
8.8 was found to be optimal for maximum yield of the
specific product for each primer set. PCR was performed
on a 5332 Thermocycler (Eppendorf, Hamburg, Ger-
many) as follows: heat inactivation of the RT at 95 °C
for 2 min, 35 cycles of denaturation at 94 °C for 1 min,
annealing at 55 °C for 1 min, extension at 72 °C for 1
min, for the first amplification; 30 cycles, using the sa-
me parameters, for the second amplification. The in-
fluenza A and B and the RSV primer set amplified spe-
cific products of the expected sizes, 169, 309 and 218
bp, respectively, which could be easily distinguished by
agarose gel electrophoresis. RNA extraction control,
containing phage MS2 RNA, was added to all samples
before extraction, while primers for phage amplification
were added after RT (RECK, RNA easy check, Ampli-
medical, Buttigliera Alta,Torino, Italy). Positive (In-
fluenza A, Influenza B and RSV plasmids) and negative
controls, included in the kit were added to each run.
Prevention of PCR contamination
To avoid contamination of reaction tubes or carry-over
with previously amplified product from other speci-
mens and controls, extraction of RNA, preparation of
reagents, first step PCR, nested PCR and amplicon de-
tection were performed in safety cabinets located in se-
parated areas of laboratory. Each cabinet was equipped
with an independent batch of reagents, micropipette
sets, sterile tubes and filtered tips.
CELL CULTURE
Conventional viral culture was performed inoculating
0.3 ml of each specimen into Madin-Darby Canine
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Kidney (MDCK) and HEp-2 cells for influenza and
RSV isolation, respectively. Virus detection was
performed by hemagglutination test and indirect im-
munofluorescence (Mouse anti-Influenza A/HA
blend and Mouse anti-Influenza B/NP blend mono-
clonal antibody, Mouse anti-RSV fusion protein 1b
monoclonal antibody and Mouse anti-RSV fusion
protein 1c monoclonal antibody, Chemicon, CA) for
influenza and RSV identification after isolation, re-
spectively [13].
Antigenic and molecular characterization
The antigenic characterization of isolates was carried
out by the haemagglutination inhibition (HI) test
using ferret post-infection sera at the WHO Influenza
Centre, London, UK. The molecular characterization
of the most representative isolates in the HI test was
carried out by sequence analysis of the globular head
region of HA protein (HA1 subunit) as described el-
sewhere [6].
DESIGN OF THE EVALUATION
Virological surveillance and influenza epidemiological
picture
Epidemiological and virological surveillance of in-
fluenza in Italy is performed by a national network, co-
ordinated by the Inter-University Centre for Research
on Influenza (CIRI) and the National Influenza Centre,
National Health Council, with the collaboration of Re-
gional Health Authorities. The sentinel network com-
prises paediatricians and practitioners, who collaborate
with hospital physicians and community officers in the
collection of specimens, in order to integrate the epide-
miological and clinical surveillance with the virologi-
cal surveillance. During the last decade (1995-2004),
antigenic and molecular characterization of the circula-
ting influenza strains revealed the presence of all 3 ty-
pes/subtypes; A/H1N1 virus was substantially stable
during that period (New Caledonia/20/99-like variant).
As far as concerns influenza virus type A/H3N2 four
Fig. 1. Phylogenetic tree of strains circulating during last decade (1995-2004).
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antigenic drifts were observed: a novel A/H3N2 antige-
nic variant (Sydney/5/97 and the subsequent variant
Panama/2007/99) appeared during the 1997/98 season
and replaced strains that were previously predominant
(Johannesburg/33/94); during the 2002/03 and 2004/05
seasons, two new A/H3N2 variants (Fujian/411/02 and
California/7/04) appeared on the epidemiological scene
[14]. The 2002/03 season was also characterized by
isolation of recombinant A/H1N2 in three children. The
phylogenetic tree is shown in Figure 1.
As far as concerns influenza virus type B, Yamaga-
ta/16/88-like strains prevailed until the 2001-02 season
when Victoria/2/87 lineage re-appeared after a decade.
A co-circulation of strains belonging to Victoria/2/87
and Yamagata/16/88 lineages was observed during the
2002/03, 2003/04 and 2004/05 seasons.
Retrospective study
(i) Specificity. In order to evaluate the specificity of
the assay, 50 nasopharyngeal swabs, collected
from patients with ILI resulting negative for In-
fluenza and RSV by nested RT-PCR and cell cul-
ture, were tested. Those included specimens posi-
tive for Adenovirus (No = 3), Mumps virus (No =
3), Parainfluenza viruses (No = 9). Furthermore,
to evaluate influenza-RSV cross-reactivity, 15 na-
sopharyngeal specimens nested-PCR and cell cul-
ture positive for Influenza (5 A/H1N1, 5 A/H3N2
and 5 B) and RSV were tested for RSV and In-
fluenza, respectively.
(ii)Analytical sensitivity. The analytical sensitivity of
the test under investigation was determined testing
serial dilution of Influenza A and B and RSV cell
culture-grown virus. The titration of viral suspen-
sion was performed by plaque reduction assay [13
15].
(iii) Clinical sensitivity. Out of 410 specimens uniplex
nested RT-PCR and culture positive for influenza, 85
were selected as representative of the circulating
strains over the last decade. In particular, 10 speci-
mens were A/H1N1/New Caledonia/20/99-like, 3
were A/H1N2 recombinants, 8 A/H3N2/Johanne-
sburg/33/94-like, 10 A/H3N2/Panama/2007/99-like,
10 A/H3N2/Fujian/411/02-like, 10 A/H3N2/Christ-
church/28/03-like, 13 were type B strains belonging
to Victoria/2/87 lineage and 15 were type B strains
belonging to Yamagata/16/88 lineage. Furthermore,
to determine the clinical sensitivity of Real Time
PCR in detecting avian influenza viruses isolated in
humans, 6 specimens culture positive for A/H5N2,
A/H7N7 and A/H9N2 were tested. The specimens
were kindly supplied by Alan Hay, WHO Collabora-
ting Centre for Reference and Research on Influen-
za, London, UK.
Sixteen and 14 specimens, collected during the last
four seasons and resulted nested RT-PCR positive for
RSV A and B, respectively, were also analysed by real-
time PCR.
Prospective study
Between 1 October 2004 and 31 January 2005, 250 spe-
cimens were collected from patients with influenza-
like illness as above described and stored into three
equal fractions: one was inoculated into the MDCK and
HEp-2 cell line for isolation of influenza and RSV vi-
ruses, one was used for nested RT-PCR and one for
real-time PCR.
Results
RETROSPECTIVE STUDY
Specificity
Out of 50 respiratory samples negative for influenza
and RSV included in specificity evaluation, 49 (98%)
resulted negative by both real-time one step RT-PCR
assays. One of the samples (2%) tested showed a fluo-
rescence increase in influenza test and was re-tested
using real-time PCR and nested PCR resulting negati-
ve by both assays (Tab. I). Probably, the fluorescence
increase was due to an aberrant signal caused by a fluo-
rescence spike. No influenza-RSV cross-reactivity was
observed with samples from a cross-reactivity panel as
all specimens nested-PCR and culture positive for in-
fluenza and RSV resulted negative when tested by real
time RT-PCR specific for detection of RSV and in-
fluenza, respectively.
Analytical sensitivity
The endpoint dilutions of 1:10,000 PFU for influenza B
and 1:100,000 PFU for influenza A and RSV viruses re-
sulted positive in every run of the real time PCR, with the
point at which the fluorescence  crosses the threshold (Ct)
mean of 31.6 ± 1.9 (95% I.C. 27-36.3), 33.2 ± 0.3 (95%
I.C. 32.4-34), and 34.1 ± 0.7 (95% I.C. 32.4-35.8) re-
spectively. The A/H1N1 dilutions corresponding to 0.13
PFU resulted positive in 1 out of 6 runs (Tab. II).
Clinical sensitivity
All influenza subtypes and variant representative of the
circulating strains in Italy between 1995 and 2004 te-
sted by influenza real-time PCR assay, as well as both
RSV A and B isolated during the last four seasons and
tested by RSV real-time PCR test, resulted positive.
The 6 avian strains all were detected by the new assay.
No signal above background was detected in these two
assays with the samples from cross-reactivity panel.
This primer set and TaqMan probe led to specific de-
tection of influenza (type A and B) and RSV (Tab. I).
PROSPECTIVE STUDY
As shown in Table III, with regard to influenza A, 37
out of 250 samples tested resulted positive by real time
PCR, in concordance with both nested PCR and cell
culture; 9 samples resulted positive by nested PCR and
negative by cell culture, resulted positive by real time
PCR. As regard as influenza B, 6 samples were positi-
ve by real time PCR, in concordance with both nested
PCR and cell culture and all sample negative by nested
PCR and cell culture also resulted negative by real time
PCR. As far as RSV, 18 swabs were positive by nested
PCR, cell culture and real time PCR and 5 resulted po-
sitive in real time PCR, in concordance with nested
PCR. Three and 5 out of 175 negative by both nested
PCR and cell culture were positive by real time PCR
for influenza A and RSV, respectively.
Discussion
Rapid detection of Influenza viruses is becoming of the
utmost importance, especially with the advent of speci-
fic antiviral drugs for influenza viruses A and B and the
emergence of highly pathogenic viruses like avian in-
fluenza A/H5N1. The efficacy of antiviral drugs largely
depends by the early administration that should be gi-
ven within 36-48 hours since the onset of symptoms.
Considering the emergence of respiratory disease cau-
sed by highly pathogenic avian influenza virus A/H5N1
in South-East Asia and the confirmation of human ca-
ses in Europe, Africa and Mid-east Asia, a rapid sensi-
tive diagnosis plays a fundamental role in early war-
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Tab. I. Specificity and clinical sensitivity evaluation.
Evaluation Sample N. Influenza Real-time PCR RSV Real-time PCR
Pos (%) Neg (%) Pos (%) Neg (%)
Specificity Influenza and RSV nested PCR neg. 50 1 (2) 49 (98) 0 50 (100)
RSV nested PCR pos 15 0 15 (100) - -
Influenza nested PCR pos 15 - - 0 15 (100)
Clinical Sensitivity 10 A/H1N1/ New Cal./20/99-like 10 10 (100) 0 - -
A/H1N2 3 3 (100) 0 - -
A/H3N2/Johannesburg/94-like 8 8 (100) 0 - -
A/H3N2/ Panama/2007/99-like 10 10 (100) 0 - -
A/H3N2/ Fuijian/411/02-like 10 10 (100) 0 - -
A/H3N2/ Christchurch/28/03-like 10 10 (100) - -
A/H5N1 2 2 (100) 0 - -
A/H7N7 2 2 (100) 0 - -
A/H9N2 2 2 (100) 0 - -
B/Yamagata-like 15 15 (100) 0 - -
B/Victoria-like 13 13 (100) 0 - -
RSV A 16 - 16 (100) 0
RSV B 14 - 14 (100) 0
Tab. II. Analytical sensitivity:obtained in analysis of serial dilution of influenza A, influenza B and RSV cell culture-grown virus.
Virus Dilution Virus Concentration Ct
(PFU) Mean ± s.d. 95% I.C. CV%
A/H3N2 Influenza 1:1 100 17.5 ± 0.5 16.7-18.3 2.9
1:10 10 20.5 ± 1.2 18.5-22.3 5.9
1:100 1 24.6 ± 0.6 23.7-25.5 2.4
1:1,000 0.1 27.5 ± 0.7 26.3-28.5 2.5
1:10,000 0.01 30.4 ± 1.2 28.5-32.3 3.9
1:100,000 0.001 33.2 ± 0.3 32.4-34 0.9
B Influenza 1:1 100 20.7 ± 0.9 19.3-22 4.3
1:10 10 23.3 ± 1.1 21.5-25.1 4.3
1:100 1 26.9 ± 1.3 24.9-28.9 4.8
1:1,000 0.1 29.3 ± 0.9 27.9-30.6 3.1
1:10,000 0.01 31.6 ± 1.9 27-36.3 6
1:100,000 0.001 -
RSV 1:1 100 19.9 ± 0.6 18.9-20.8 3
1:10 10 23.5 ± 1 22-25.1 4.3
1:100 1 26.7 ± 1.2 24.8-28.5 4.5
1:1,000 0.1 29.8 ± 1.8 26.9-36.7 6
1:10,000 0.01 32.3 ± 2 29.1-35.5 6.2
1:100,000 0.001 34.1 ± 0.7 32.4-35.8 2.1
ning of surveillance system. Amplification techniques
are particularly beneficial to survey difficult-to-culture
organisms, such as RSV. Laboratory methods as cells
culture are labor-intensive and time consuming. PCR
based tests are considered the gold standard for detec-
tion of respiratory viruses [16-18] even if the applica-
tion of a PCR panel to respiratory specimens has the di-
sadvantage of requiring the use of different tubes for
each sample thus increasing the risk of cross contami-
nation and the presence of a multiple primer sets may
affect the specificity and sensitivity of the assays. The
real time PCR approach overcomes these limitations.
In this study is reported the evaluation of two real-time
one step RT-PCR assays as sensitive methods for de-
tection of respiratory viruses using a close-tube system
that minimizes the risk of contamination and a single
step procedure easy and rapid to perform. The findings
showed that our assays are highly specific and sensiti-
ve for detection of all tested influenza A and B virus
strains, belonging to all subtypes and lineages within
subtypes, and RSV type A and B.
As regard as clinical evaluation, these two real-time
PCR detected all viral culture- and multiplex-nested
PCR positive clinical samples. The data of prospective
study highlighted that the real time PCR was more sen-
sitive than both cell culture and nested-PCR, showing
that some positive samples could be missed by routine
methods. The analytical sensitivity resulted from
analysis of a dilution series of a cell culture-grown vi-
rus showed that the sensitivity was increased by up to a
factor of 100 with respect to multiplex for influenza A
and B and RSV viruses. These results are extremely
important in routine diagnostics studies particularly
when the amount of virus RNA in specimens is low.
In conclusion, this two new real-time PCR showed to
be specific and sensitive in rapid detection of influenza
and RSV. They could represent an important tool for
human influenza surveillance due to both human and
avian influenza virus; moreover they are not affected
by differences in the circulating strain so that also drif-
ted viruses could be detected such as viruses belonging
to subtypes other than A/H3N2 or A/H1N1, such as
A/H5N1, A/H7N7 and A/H9N2.
A rapid detection of RSV is necessary since RSV is the
most common viral pathogen for lower respiratory tract
infection among infants and young children and an im-
portant agent for respiratory disease in the elderly and
in transplant patients.
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Tab. III. Results obtained in analysis of 250 specimens collected during the 2004/05 season.
Influenza A Influenza B RSV N. Real time PCR
Nested Cell cult. Nested Cell cult. Nested Cell cult. Influ A Influ B RSV
PCR PCR PCR Pos Pos Pos
Pos Pos Neg Neg Neg Neg 37* 37 0 0
Pos Neg Neg Neg Neg Neg 9 9 0 0
Neg Neg Pos Pos Neg Neg 6 0 6 0
Neg Neg Pos Neg Neg Neg 0 0 0 0
Neg Neg Neg Neg Pos Pos 18 0 0 18
Neg Neg Neg Neg Pos Neg 5 0 0 5
Neg Neg Neg Neg Neg Neg 175° 3 0 5
250
* 1 A/H1N1/New Caledonia-like, 5 A/H3N2/Panama-like, 31 A/H3N2/California/7/04-like; °3 A/H3N2 and 5 RSV
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